Ablating short-segment Barrett esophagus: What’s your weapon of choice?

August 7th, 2011

Ablating short-segment Barrett esophagus: What’s your weapon of choice?

The first cases of Barrett esophagus (BE) ablation in the late 1980s used YAG and Argon laser. Since then, a myriad of ablation techniques have been described, including multipolar electrocautery (MPEC), argon plasma coagulation (APC), cryotherapy, radiofrequency ablation (RFA), and endoscopic mucosal resection (EMR). Each technique has had its advocates, and some of the techniques appear to have certain advantages in certain types of BE: e.g., long segment, nodular, etc.

Most cases of BE are short segment, and most neoplastic cases do not have nodules or erosions. So the question I would like to see discussed is: In a patient with 1–2 cm of otherwise featureless flat but neoplastic BE:

What ablation technique would you use, and what do you feel makes this technique advantageous?

What would be your second option, and when would you employ it?

Do you use more than one technique, and, if so, which ones do you use and why?

What are the most common complications you see with BE ablation?

What is your overall success at complete BE elimination?

We look forward to your comments.

Categories: Patient care
Tags: Barrett esophagus

You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

The Growing Success of Medicare Drug-Price Negotiation February 26, 2026

Medicare will achieve greater savings on the 15 drugs in its second round of price negotiations than it did in the first round. Despite new challenges, the effort should continue to pay growing dividends.

Group B Streptococcal Disease February 26, 2026

Group B streptococcal infection mostly affects newborns, infants, pregnant persons, and older adults. Perinatal prevention is successful but contributes to antibiotic exposure. Multivalent glycoconjugate vaccines are in development.

Hepatic Angiosarcoma February 12, 2026

A 60-year-old man presented with a 15-day history of generalized weakness and right upper abdominal pain. Imaging studies revealed diffuse disruption of the hepatic architecture by hyperechoic nodules and areas of necrosis and hemorrhage.

CORE Principles in the Management of Severe Hypertriglyceridemia January 29, 2026

Management of hypertriglyceridemia for reducing the risk of serious clinical complications, including hypertriglyceridemia-induced acute pancreatitis, has historically been formidable and frustrating for clinicians and patients. Challenges are related to variable success in adherence to the lifestyle modifications that are required to reduce triglyceride levels, the predominantly polygenic and multifactorial determinants...

Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk January 29, 2026

In two phase 3 trials involving patients with severe hypertriglyceridemia, olezarsen led to a significantly greater reduction in the triglyceride level and in acute pancreatitis events than placebo.

Gut Check on Gastroenterology Archive

Gut Check on Gastroenterology, an NEJM Journal Watch blog focusing on issues in clinical gastroenterology, was active from 2008 to 2014. This archive contains all posts and discussions from Gut Check’s history.

August 7th, 2011